Answers are grounded in this paper and cite their sources.
Micro- and nanoplastics (MNPs) have emerged as ubiquitous environmental pollutants, infiltrating terrestrial, aquatic, and atmospheric ecosystems. Recent research highlights a critical, bidirectional relationship between these particles and microbiota, particularly within the gastrointestinal (GI) tract of humans and animals. The gut microbiota, a complex and diverse community of trillions of microbes residing in the human GI tract, plays a critical role in host digestion, metabolism, immune function, and overall health. Disruption of this microbial ecosystem, known as dysbiosis, has been linked to a wide range of diseases. MNP-induced gut dysbiosis also involves complex molecular mechanisms requiring integrative approaches. Multi-omics technologies are essential to identify pathways affected by exposure, including immune responses, oxidative stress, and host-microbe interactions. However, their use in human studies remains limited. Large-scale longitudinal studies combined with multi-omics analyses are crucial to clarify systemic health implications of microplastic exposure and develop mitigation strategies.
No takes yet. Share an insight, caveat, or question.
Dutta et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: